548 related articles for article (PubMed ID: 28993955)
1. The c.29T>C polymorphism of the transforming growth factor beta-1 (TGFB1) gene, bone mineral density and the occurrence of low-energy fractures in patients with inflammatory bowel disease.
Krela-Kaźmierczak I; Michalak M; Wawrzyniak A; Szymczak A; Eder P; Łykowska-Szuber L; Kaczmarek-Ryś M; Drwęska-Matelska N; Skrzypczak-Zielińska M; Linke K; Słomski R
Mol Biol Rep; 2017 Dec; 44(6):455-461. PubMed ID: 28993955
[TBL] [Abstract][Full Text] [Related]
2. Bone mineral density and the 570A>T polymorphism of the bone morphogenetic protein 2 (BMP2) gene in patients with inflammatory bowel disease: a cross-sectional study.
Krela-Kazmierczak I; Wawrzyniak A; Szymczak A; Eder P; Lykowska-Szuber L; Michalak M; Drweska-Matelska N; Kaczmarek-Rys M; Skrzypczak-Zielinska M; Szalata M; Slomski R
J Physiol Pharmacol; 2017 Oct; 68(5):757-764. PubMed ID: 29375051
[TBL] [Abstract][Full Text] [Related]
3. Large-scale analysis of association between polymorphisms in the transforming growth factor beta 1 gene (TGFB1) and osteoporosis: the GENOMOS study.
Langdahl BL; Uitterlinden AG; Ralston SH; Trikalinos TA; Balcells S; Brandi ML; Scollen S; Lips P; Lorenc R; Obermayer-Pietsch B; Reid DM; Armas JB; Arp PP; Bassiti A; Bustamante M; Husted LB; Carey AH; Pérez Cano R; Dobnig H; Dunning AM; Fahrleitner-Pammer A; Falchetti A; Karczmarewicz E; Kruk M; van Leeuwen JP; Masi L; van Meurs JB; Mangion J; McGuigan FE; Mellibovsky L; Mosekilde L; Nogués X; Pols HA; Reeve J; Renner W; Rivadeneira F; van Schoor NM; Ioannidis JP; ; ; ; ; ; ; ;
Bone; 2008 May; 42(5):969-81. PubMed ID: 18284942
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D receptor (VDR) TaqI polymorphism, vitamin D and bone mineral density in patients with inflammatory bowel diseases.
Szymczak-Tomczak A; Krela-Kaźmierczak I; Kaczmarek-Ryś M; Hryhorowicz S; Stawczyk-Eder K; Szalata M; Skrzypczak-Zielińska M; Łykowska-Szuber L; Eder P; Michalak M; Dobrowolska A; Słomski R
Adv Clin Exp Med; 2019 Jul; 28(7):955-960. PubMed ID: 30929318
[TBL] [Abstract][Full Text] [Related]
5. Genetic variants of MTHFR gene in relation to folic acid levels and bone mineral density in Polish patients with inflammatory bowel disease.
Ratajczak-Pawłowska AE; Hryhorowicz S; Szymczak-Tomczak A; Wysocka E; Michalak M; Kaczmarek-Ryś M; Lis-Tanaś E; Bielawska L; Pławski A; Słomski R; Dobrowolska A; Krela-Kaźmierczak I
J Appl Genet; 2024 Feb; 65(1):73-81. PubMed ID: 37816983
[TBL] [Abstract][Full Text] [Related]
6. Bone Metabolism and the c.-223C > T Polymorphism in the 5'UTR Region of the Osteoprotegerin Gene in Patients with Inflammatory Bowel Disease.
Krela-Kaźmierczak I; Kaczmarek-Ryś M; Szymczak A; Michalak M; Skrzypczak-Zielińska M; Drwęska-Matelska N; Marcinkowska M; Eder P; Łykowska-Szuber L; Wysocka E; Linke K; Słomski R
Calcif Tissue Int; 2016 Dec; 99(6):616-624. PubMed ID: 27639566
[TBL] [Abstract][Full Text] [Related]
7. Bone mineral density in Iranian patients with inflammatory bowel disease.
Zali M; Bahari A; Firouzi F; Daryani NE; Aghazadeh R; Emam MM; Rezaie A; Shalmani HM; Naderi N; Maleki B; Sayyah A; Bashashati M; Jazayeri H; Zand S
Int J Colorectal Dis; 2006 Dec; 21(8):758-66. PubMed ID: 16463035
[TBL] [Abstract][Full Text] [Related]
8. Altered bone metabolism in inflammatory bowel disease: there is a difference between Crohn's disease and ulcerative colitis.
Ardizzone S; Bollani S; Bettica P; Bevilacqua M; Molteni P; Bianchi Porro G
J Intern Med; 2000 Jan; 247(1):63-70. PubMed ID: 10672132
[TBL] [Abstract][Full Text] [Related]
9. Bone density and bone metabolism in patients with inflammatory bowel disease.
Shirazi KM; Somi MH; Rezaeifar P; Fattahi I; Khoshbaten M; Ahmadzadeh M
Saudi J Gastroenterol; 2012; 18(4):241-7. PubMed ID: 22824766
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D, Vitamin D Receptor (VDR) Gene Polymorphisms (ApaI and FokI), and Bone Mineral Density in Patients With Inflammatory Bowel Disease.
Szymczak-Tomczak A; Kaczmarek-Ryś M; Hryhorowicz S; Michalak M; Eder P; Skrzypczak-Zielińska M; Łykowska-Szuber L; Tomczak M; Słomski R; Dobrowolska A; Krela-Kaźmierczak I
J Clin Densitom; 2021; 24(2):233-242. PubMed ID: 33172802
[TBL] [Abstract][Full Text] [Related]
11. Risk Factors for Low Bone Density in Inflammatory Bowel Disease: Use of Glucocorticoids, Low Body Mass Index, and Smoking.
Even Dar R; Mazor Y; Karban A; Ish-Shalom S; Segal E
Dig Dis; 2019; 37(4):284-290. PubMed ID: 30799399
[TBL] [Abstract][Full Text] [Related]
12. Reduced bone mass and preserved marrow adipose tissue in patients with inflammatory bowel diseases in long-term remission.
Bastos CM; Araújo IM; Nogueira-Barbosa MH; Salmon CEG; de Paula FJA; Troncon LEA
Osteoporos Int; 2017 Jul; 28(7):2167-2176. PubMed ID: 28405731
[TBL] [Abstract][Full Text] [Related]
13. Risk Factors of Low Bone Mineral Density in Newly Diagnosed Pediatric Inflammatory Bowel Disease.
Ahn MB; Yoo IH
Nutrients; 2023 Dec; 15(24):. PubMed ID: 38140307
[TBL] [Abstract][Full Text] [Related]
14. The genetically predicted causal relationship of inflammatory bowel disease with bone mineral density and osteoporosis: evidence from two-sample Mendelian randomization.
Xu D; Chen Y; Gao X; Xie W; Wang Y; Shen J; Yang G; Xie B
Front Immunol; 2023; 14():1148107. PubMed ID: 37275908
[TBL] [Abstract][Full Text] [Related]
15. Bone mineral density in patients with inflammatory bowel disease: a population-based prospective two-year follow-up study.
Jahnsen J; Falch JA; Mowinckel P; Aadland E
Scand J Gastroenterol; 2004 Feb; 39(2):145-53. PubMed ID: 15000276
[TBL] [Abstract][Full Text] [Related]
16. Physical activity, quality of diet and bone mineral density in patients with inflammatory bowel disease.
Ratajczak-Pawłowska AE; Michalak M; Szymczak-Tomczak A; Rychter AM; Zawada A; Skoracka K; Dobrowolska A; Krela-Kaźmierczak I
J Hum Nutr Diet; 2023 Oct; 36(5):1692-1700. PubMed ID: 37403249
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of osteoporosis and osteopenia in a population of patients with inflammatory bowel diseases from the Wielkopolska Region.
Krela-Kaźmierczak I; Michalak M; Szymczak-Tomczak A; Łykowska-Szuber L; Stawczyk-Eder K; Waszak K; Kucharski MA; Dobrowolska A; Eder P
Pol Arch Intern Med; 2018 Aug; 128(7-8):447-454. PubMed ID: 30057387
[TBL] [Abstract][Full Text] [Related]
18. Genetic polymorphism of ABCB1 gene (C3435T) in patients with inflammatory bowel diseases. Is there any gender dependency?
Jaźwińska-Tarnawska E; Jęśkowiak I; Waszczuk E; Mulak A; Głowacka K; Hurkacz M; Paradowski L; Zaleska Z; Wiela-Hojeńska A
Pharmacol Rep; 2015 Apr; 67(2):294-8. PubMed ID: 25712653
[TBL] [Abstract][Full Text] [Related]
19. T-1213C polymorphism of estrogen receptor beta is associated with low bone mineral density and osteoporotic fractures.
Kung AWC; Lai BMH; Ng MYM; Chan V; Sham PC
Bone; 2006 Nov; 39(5):1097-1106. PubMed ID: 16777502
[TBL] [Abstract][Full Text] [Related]
20. Analysis of risk factors for low bone mineral density in inflammatory bowel disease.
Frei P; Fried M; Hungerbuhler V; Rammert C; Rousson V; Kullak-Ublick GA
Digestion; 2006; 73(1):40-6. PubMed ID: 16543736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
